Yu‐Suo Tong

1.4k total citations
24 papers, 1.1k citations indexed

About

Yu‐Suo Tong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yu‐Suo Tong has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Yu‐Suo Tong's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Esophageal Cancer Research and Treatment (6 papers). Yu‐Suo Tong is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Esophageal Cancer Research and Treatment (6 papers). Yu‐Suo Tong collaborates with scholars based in China and United States. Yu‐Suo Tong's co-authors include Xi‐Lei Zhou, Xiufeng Cao, Qingquan Wu, Weihong Shi, Jin Lv, Tongxin Yang, Zi-Hao Liu, Yingjian Song, Xiaowei Wang and Yaqi Song and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Neuroreport.

In The Last Decade

Yu‐Suo Tong

23 papers receiving 1.1k citations

Peers

Yu‐Suo Tong
Justin S. Gundara Australia
Weiyu Xu China
Hang Yang China
Kazuhiro Nagao Japan
Eduardo Cervera Mexico
Libing Xiang China
Yushen Wu China
Tomofumi Yohena Japan
N. Stafford United Kingdom
Justin S. Gundara Australia
Yu‐Suo Tong
Citations per year, relative to Yu‐Suo Tong Yu‐Suo Tong (= 1×) peers Justin S. Gundara

Countries citing papers authored by Yu‐Suo Tong

Since Specialization
Citations

This map shows the geographic impact of Yu‐Suo Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Suo Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Suo Tong more than expected).

Fields of papers citing papers by Yu‐Suo Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Suo Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Suo Tong. The network helps show where Yu‐Suo Tong may publish in the future.

Co-authorship network of co-authors of Yu‐Suo Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Suo Tong. A scholar is included among the top collaborators of Yu‐Suo Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Suo Tong. Yu‐Suo Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tong, Yu‐Suo, et al.. (2024). Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer-associated fibroblasts. Frontiers in Oncology. 14. 1412660–1412660. 2 indexed citations
3.
Tong, Yu‐Suo, et al.. (2023). Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma. Frontiers in Oncology. 13. 1257266–1257266. 7 indexed citations
4.
Xu, Yingying, Xi‐Lei Zhou, Changhua Yu, et al.. (2021). Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. Frontiers in Oncology. 11. 655071–655071. 9 indexed citations
5.
Xu, Yingying, et al.. (2021). Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus. International Journal of General Medicine. Volume 14. 3929–3939. 2 indexed citations
6.
7.
Tong, Yu‐Suo, Lili Yang, Changhua Yu, et al.. (2020). Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs. Molecular Therapy — Oncolytics. 18. 1–13. 73 indexed citations
8.
Zhou, Xi‐Lei, Weiguo Zhu, Zhijian Zhu, et al.. (2019). Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy. The Oncologist. 24(8). e677–e686. 29 indexed citations
9.
Zhou, Xi‐Lei, et al.. (2018). Combination of long noncoding RNA <em>MALAT1</em> and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. OncoTargets and Therapy. Volume 11. 2333–2344. 17 indexed citations
10.
Tong, Yu‐Suo, Juan Tan, Xi‐Lei Zhou, Yaqi Song, & Yingjian Song. (2017). Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. Journal of Translational Medicine. 15(1). 221–221. 174 indexed citations
11.
Zhou, Xi‐Lei, Yongqiang Li, Weiguo Zhu, et al.. (2017). Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Scientific Reports. 7(1). 42581–42581. 43 indexed citations
12.
Tong, Yu‐Suo, Juan Tan, & Xi‐Lei Zhou. (2016). Clinical significance circulating long non-coding RNA H19 in plasma of patients with lung cancer. Chinese Journal of Asthma. 36(23). 1809–1813. 1 indexed citations
13.
Song, Yaqi, Xin-Le Kang, Gang Cao, et al.. (2016). Clinical characteristics and prognostic factors of brain central neurocytoma. Oncotarget. 7(46). 76291–76297. 9 indexed citations
14.
15.
Tang, Weiwei, Suqing Li, Yu‐Suo Tong, et al.. (2015). Implication of lncRNAs in pathogenesis of esophageal cancer. OncoTargets and Therapy. 8. 3219–3219. 15 indexed citations
16.
Shi, Weihong, Qingquan Wu, Suqing Li, et al.. (2015). Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumor Biology. 36(4). 2501–2507. 87 indexed citations
17.
Tong, Yu‐Suo, Xiaowei Wang, Xi‐Lei Zhou, et al.. (2015). Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Molecular Cancer. 14(1). 3–3. 287 indexed citations
18.
Tong, Yu‐Suo, Xi‐Lei Zhou, Xiaowei Wang, et al.. (2014). Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. Journal of Translational Medicine. 12(1). 233–233. 83 indexed citations
19.
Wu, Qingquan, Bin Zhu, Fangjun Chen, et al.. (2014). Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumor Biology. 35(8). 7743–7754. 97 indexed citations
20.
Wang, Chunmei, Qingquan Wu, Suqing Li, et al.. (2013). Upregulation of the Long Non-coding RNA PlncRNA-1 Promotes Esophageal Squamous Carcinoma Cell Proliferation and Correlates with Advanced Clinical Stage. Digestive Diseases and Sciences. 59(3). 591–597. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin S. Gundara Breakdown of academic impact, for papers by Weiyu Xu Breakdown of academic impact, for papers by Hang Yang Breakdown of academic impact, for papers by Kazuhiro Nagao Breakdown of academic impact, for papers by Eduardo Cervera Breakdown of academic impact, for papers by Libing Xiang Breakdown of academic impact, for papers by Yushen Wu Breakdown of academic impact, for papers by Tomofumi Yohena Breakdown of academic impact, for papers by N. Stafford
Rankless by CCL
2026